Is MYX a bargain, page-1947

Absolutely correct KP. And SGH directors had plenty
of skin in the game but large offshore poorly thought
out acquisition sunk them in the end. Hopefully this
goes better for MYX shareholders....Too many eggs
in Mithra’s basket for my liking. Objectively if I had no
shares in either company previously and looked at the
track record of both companies it would make far more
sense to invest in Mithra as Mayne carries the burden
of price erosion and competition on Generics. As
previously said if this acquisition was funded by debt
Mayne would have been in Administration quite some
time ago. So who picked up the tab for the poorly
thought through AUD $1 billion acquisition that SR
advocated for that was going to drive profits and create
share holder value? Yep that same guy banging on
about another great deal yet to be tested by the market.
So impressed by his own deal making and driving medium
to long term profits that he hasn’t even bought one share in his
own company that he apparently believes in so much. Same
second rate strategy, same second rate result. Most people on here
would be happy just to get their money back because no one
genuinely trusts SR. It’s just so blatantly obvious to everyone.
And Charts was banging on about trumped up exagerated
profits on E4. I challenged him on his BS comparisons to CSL.
That was what really got the alarm bells ringing for me. Never
listen to the story look at the facts. The share price from 2016,
$2+ tells the real story. SR-driving share holder value.....DOWN!
It’s a loss making business that has so far destroyed share holder
wealth to the tune of 80%+ in 4 years, that’s 20% loss YOY for 4
years just for new share holders looking to get on board because
you’ll find precious little information in regards to announcements
of any substance from SR. Constant spin on consistently poor
results excusing himself and blaming external forces...He can’t
blame the Teva deal of the decade on external forces because
he made that almost fatal decision himself!!!! Only reason he’s still
there is because he tapped SH’s with a wealth destroying CR, otherwise
he would have presided over another Australian guaranteed offshore
corporate failure. Then not longer after the Teva deal the company is
mysteriously changing direction, like why? It was such a great acquisition
so why would you want to change direction after that wealth creating
acquisition? ....No apology from SR about losing a lot of people hundreds
of millions of $$$$, but guess what? Easy come easy go. Mayne has no
decent products of their own and SR knows it so he gets into women’s
health and changes direction on a whim. A generic Nuvaring nowhere
to be seen and a promising untested OCP....Go back and reread E4
information. SR has been completely non committal about what he has
said about it. All he’s done is regurgitated the words of Mithra’s CEO
like a cockatoo and promised 9.65% of Mayne to Mithra as well as a
whole pile of cash. That’s SR’s second deal of the decade. All hype, up
front costs and no product on the market. E4 in 2021....doubt it, can’t
even get a generic Nuvaring approval after 3 years....